US Patent Issued to Ceruvia Lifesciences on April 7 for "2-bromo-lysergic acid diethylamide for substance abuse" (Connecticut Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,272, issued on April 7, was assigned to Ceruvia Lifesciences LLC (Greenwich, Conn.).

"2-bromo-lysergic acid diethylamide for substance abuse" was invented by Carey Turnbull (Greenwich, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating substance abuses in an individual, by administering 2-bromo-lysergic acid diethylamide (BOL-148) to an individual and reducing use of the substance."

The patent was filed on March 25, 2021, under Application No. 17/913,471.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsea...